Teleflex Incorporated

NYSE:TFX

Medical - Instruments & Supplies

Healthcare
$165.85 +0.83%

+$1.04 today

Market cap
$6.58B
Beta
0.82
P/E (TTM)
-5.5
EPS (TTM)
-$22.79
Dividend yield
1.08%
52W Low $100.18High $139.67

Volume 1.16M

Average 0.80M

TFX Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Teleflex IncorporatedNYSE: TFX

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) declines year over year

Q2 FY2026 weighted avg shares (diluted) of 43.66M shares fell 4.9% year over year, in line with the -4.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.3% from the prior quarter. Over 3 fiscal years it compounded at -1.9% a year.

Context

  • Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -4.9% toward the trailing-twelve-month pace of -4.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
43.66M-1.3% QoQ
Last fiscal yearDec 2025
44.72M-5.0% YoY
LTMJun 2026
44.1M-4.8% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.9%——
1 year-5.0%——
3-year CAGR-1.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
44.72M USD
Year-over-year change
-5.0%
4-year CAGR
-1.5%

Weighted Avg Shares (Diluted) vs competitors

How TFX compares with its peers on the latest reported figures

  • TFX's LTM Jun 2026 weighted avg shares (diluted) of 44.1M shares is the 10th highest of the 11 companies compared; the peer median is 140.55M shares.
  • Its year-over-year change of -4.8% is the lowest of 11, against a peer median of +1.1%.
  • Over three fiscal years its annual growth of -1.9% compares with a peer median of +5.2%.
TFX Competitors Peer median
Weighted Avg Shares (Diluted) for TFX and competitors
Company Period LTM YoY 3-year CAGR
BLCOBausch + Lomb CorporationLTM Jun 2026355.23M +0.6%+0.4%
STVNStevanato Group S.p.A.LTM Jun 2026273.01M +0.0%+1.0%
ALKSAlkermes plcLTM Sep 2026169.48M +0.9%+1.0%
TGTXTG Therapeutics, Inc.LTM Sep 2026158.16M -2.2%+6.0%
ARWRArrowhead Pharmaceuticals, Inc.LTM Sep 2026142.03M +6.4%+9.9%
PCVXVaxcyte, Inc.LTM Jun 2026139.07M +7.3%+28.0%
CRSPCRISPR Therapeutics AGLTM Sep 202694.81M +8.4%+5.0%
PTCTPTC Therapeutics, Inc.LTM Jun 202685.59M +7.4%+7.2%
MMSIMerit Medical Systems, Inc.LTM Sep 202660.11M -0.8%+1.6%
TFXTeleflex IncorporatedLTM Jun 202644.1M -4.8%-1.9%
KRYSKrystal Biotech, Inc.LTM Jun 202630.24M +1.3%+5.5%
Peer median (excluding TFX) 140.55M+1.1%+5.2%

Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.81B2.79B2.97B3.05B1.99B
Cost of Revenue1.26B1.26B1.33B1.34B871.96M
Gross Profit1.55B1.53B1.65B1.7B1.12B
Gross Margin55.2%54.9%55.4%55.9%56.2%
Research & Development130.84M153.82M154.35M161.67M144.78M
Selling, General & Admin860.09M863.75M929.87M995.27M720.17M
Operating Expenses921.51M1.03B1.14B1.55B864.95M
Depreciation & Amortization237.36M230.59M242.12M274.6M177.74M
EBITDA853.8M730.77M761.21M433.62M302.51M
EBITDA Margin30.4%26.2%25.6%14.2%15.2%
Operating Income628.1M499.73M506.31M151.01M255.8M
Operating Margin22.4%17.9%17.0%5.0%12.8%
Interest Income1.33M912K12.78M8.01M6.4M
Interest Expense56.97M54.26M85.08M83.54M100.22M
Other Income / Expenses(68.63M)(53.81M)(72.3M)(75.54M)(231.25M)
Income Before Tax559.47M445.92M434.01M75.48M24.55M
Pre-Tax Margin19.9%16.0%14.6%2.5%1.2%
Income Tax Expense74.35M83M76.44M5.32M(33.98M)
Net Income485.37M363.14M356.33M69.68M(905.64M)
Net Margin17.3%13.0%12.0%2.3%-45.4%
EPS (Basic)10.387.747.581.49(20.30)
EPS (Diluted)10.237.687.531.48(20.25)
Weighted Avg Shares46.77M46.9M46.98M46.84M44.62M
Weighted Avg Shares (Diluted)47.43M47.31M47.3M47.09M44.72M

Teleflex Incorporated

NYSE:TFX

Intrinsic Alpha fair value

Locked

Current Price

$165.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.